Isomorphic Labs 是一家专注于人工智能药物发现的平台，成立于2021年，源自谷歌的 DeepMind。近日，该公司 首次 获得外部融资，共计6亿美元轮融资由 Thrive Capital 领投，参与者包括 GV 和现有投资者 ...

Isomorphic Labs, an Alphabet-backed AI biotech firm, raised $600M to boost its AI drug design engine, expand clinical ...

Isomorphic Labs, the AI drug-discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital ...

Isomorphic Labs says it is advancing drug design programs across multiple therapeutic areas and drug modalities. These ...

你知道吗？人工智能正在快速改变制药行业，呼唤着新的药物研发方式。最近，英国的Isomorphic Labs宣布融资6亿美元，这不仅是为了提升其AI药物设计引擎的速度，更是为了向AI攻克疾病的宏伟目标迈出一步。

The company, which uses artificial intelligence to develop new treatments, now counts the venture capital firm Thrive Capital ...

在科技飞速发展的当下，制药行业也在迎来一场颠覆性的变革。近日，位于英国的Isomorphic Labs像一颗璀璨的新星，吸引了全世界的目光。这个被誉为“魔法实验室”的公司，宣布成功融资6亿美元，目标是加快其人工智能技术的研发和应用，实现药物开发的重大突破。

AlphaFold 3, the improved version of the model used by Isomorphic Labs’ drug design engine, debuted last May. It can predict ...

Investing.com — Alphabet Inc.旗下利用人工智能 (AI)进行药物发现的公司Isomorphic Labs已获得6亿美元的融资。这是该公司首次获得外部资金。 此轮融资由Thrive ...

The London-based business – which launched in 2021 – will use the funds to further its research, expand its team and continue ...

Isomorphic Labs, which uses artificial intelligence technologies for drug discovery, has raised $600 million in its first ...

The funding is set to accelerate the development of Isomorphic’s AI drug design engine and advance clinical programmes.